Article

Klotho Neurosciences has completed the acquisition of Greenland Mines Corp., securing an 80% interest in the Skaergaard Project in Southeast Greenland, valued at $68 billion. The merger agreement was signed on March 3, 2026, with the acquisition closing on March 4.

Klotho will now operate in two divisions: Natural Resources, focused on the Skaergaard Project, and Cell and Gene Therapy. The acquisition was executed through convertible preferred stock, subject to shareholder approval, potentially allowing Greenland Mines to own approximately 93% of Klotho. The Skaergaard Project represents a significant strategic asset amid global supply chain risks for palladium and platinum, critical for various industries.